A scientist, Jiankui
The Chinese Academy of Medical Sciences responded: "we are opposed to any clinical operation of human embryo genome editing for reproductive purposes in violation of laws, regulations, and ethical norms in the absence of full scientific evaluation". 1 The National
Health Commission of China responded: "This illegal behavior will be verified and punished". 2 The genetic alteration of human eggs, sperm, and embryos is prohibited for germ line purposes. The relevant guidelines already exist in China. Jiankui He's work violated those guidelines.
CRISPR/Cas9 techniques have been applied in many kinds of animals, including human cells. It is very clear that this system can be used to genetically modify the human germ line today. However, many questions remain to be answered before this technique can be used to alter the human genome for reproductive purposes.
Although the intent may be to create perfect human beings, the result may be a monster.
WH AT IS CRISPR/ CAS9?
Mammalian genomes contain billions of base pairs and are difficult to manipulate. With the development of homologous recombination (HR), we can precisely modify the genome, with expected outcomes.
However, precise HR-mediated alteration occurs at a very low frequency (one in 10 6 -10 9 cells). 3 A series of programmable nucleasebased genome editing tools, such as Zinc finger nucleases (ZFNs), 4 transcription activator-like effector nucleases (TALENs) [5] [6] [7] and the RNA-guided DNA endonuclease Cas9 (CRISPR/Cas9), [8] [9] [10] have been developed in recent years, which enable efficient genetic modifications of many species. The ZFNs were derived from eukaryotic transcription factors, 4 TALENs were derived from Xanthomonas bacteria, [5] [6] [7] and CRISPR/Cas9 was derived from the type II CRISPR system. [8] [9] [10] Of the current genome editing tools, the RNA-guided Cas9 system has been developed most rapidly. This system can easily be used to target a genomic locus with a small guide RNA (sgRNA) complementary to the target DNA sequence. 11, 12 CRISPRs were first reported in Escherichia coli in 1987 and are present in over 40% of sequenced bacteria and 90% of sequenced archaea. 13 Currently, the type II CRISPR system, first identified as part of an adaptive immunity system that protects the hosts against invasion by plasmids and other DNA contaminants, is the most commonly used. 14, 15 Since the first report of CRISPR/Cas9 techniques being used for gene targeting in mammalian cells in 2013, these techniques have been applied in many species. 8, 10, 16, 17 In theory, they can be used for human germ line modification, but there are still many open questions to be solved before any attempts to apply it should be made.
Targeting difficulties
All programmable nuclease-based editing tools work via introduction of a site-specific DNA double strand break (DSB). [4] [5] [6] [7] [8] [9] [10] 18 The DSB will stimulate DNA repair through nonhomologous end-joining (NHEJ) and/or homologous recombination (HR)-directed repair mechanisms.
HR-mediated repair occurs only in specific phases of the cell cycle (G2 and S), while NHEJ-mediated repair occurs throughout the cell's life. NHEJ-mediated repair is the primary damage-mediated repair mechanism. NHEJ-mediated repair is not an entirely accurate progress and may induce small deletions or insertions at the target sequence. In order to achieve very precise genome modification, various kinds of CRISPR-based genome editing tools were developed including adenine base editors (ABEs), cytosine base editors3 (BE3), and so on. 19 
Off-target effects
The most important concern a newly developed gene editing tool 
Mosaic issue
The CRISPR/Cas9 system may continue to work beyond one-cell fertilized eggs and result in a mosaic genotype. 10, [29] [30] [31] This means that different tissues or organs will have different genetic modifications, even within the same organism. We are still uncertain what the effects of the gene editing would be in the genome of babies.
WHICH IS THE PERFECT TARGET G ENE?
In order to select the perfect target gene and an efficient target site, and is highly expressed in bone marrow-derived cells including T cells and macrophages. 32 In other tissues, CCR5 is expressed on epithelium, endothelium, vascular smooth muscle, and fibroblasts. [33] [34] [35] Many studies have demonstrated that CCR5 has an important role in HIV virus infection. 36, 37 CCR5 is therefore a potential target for HIV infection protection. In another study, however, Ccr5 gene deletion also showed lupus nephritis susceptibility. 38 In the central nervous system, Ccr5 is expressed on neurons, astrocytes, and microglia and functions as a suppressor for cortical plasticity and hippocampal learning and memory. 35 The Ccr5 gene function in many tissues is still unclear. Deletion of this gene may result in unexpected disease. 38 It is therefore a very risky target for gene editing.
ETHICAL PROBLEMS
The scientific community has already developed a broad social consensus about the application of these techniques. It strongly encourages basic research and manipulation in laboratories, but does not condone use of the technique for genetically altering human babies.
We agree with the major recommendations:
Research: "Intensive" research is encouraged and should proceed, While regulations and guidelines already exist and regulate government-funded studies, but there are few restrictions for privately funded research. The CRISPR technique is still in the initial stages of evaluation and it is premature to consider it for clinical use, especially for reproductive purposes. In order to avoid the birth of "a second CRISPR baby," we strongly recommend that the government should regulate clinical experiments using this technique for human reproductive purpose.
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